Madhu V. Singh

1.9k total citations
43 papers, 1.3k citations indexed

About

Madhu V. Singh is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Immunology. According to data from OpenAlex, Madhu V. Singh has authored 43 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 12 papers in Cardiology and Cardiovascular Medicine and 7 papers in Immunology. Recurrent topics in Madhu V. Singh's work include Angiogenesis and VEGF in Cancer (6 papers), Cardiac electrophysiology and arrhythmias (5 papers) and Stress Responses and Cortisol (4 papers). Madhu V. Singh is often cited by papers focused on Angiogenesis and VEGF in Cancer (6 papers), Cardiac electrophysiology and arrhythmias (5 papers) and Stress Responses and Cortisol (4 papers). Madhu V. Singh collaborates with scholars based in United States, Canada and India. Madhu V. Singh's co-authors include François M. Abboud, Mark E. Anderson, Mark W. Chapleau, Robert M. Weiss, Sailesh Harwani, Elizabeth D. Luczak, William Kutschke, Paari Dominic Swaminathan, Xiaoqun Guan and P. Anthony Weil and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Circulation and Journal of Clinical Investigation.

In The Last Decade

Madhu V. Singh

40 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Madhu V. Singh United States 17 702 531 188 158 127 43 1.3k
Ellen A. Bernstein United States 24 504 0.7× 479 0.9× 293 1.6× 148 0.9× 86 0.7× 46 1.4k
Ya Su United States 21 684 1.0× 642 1.2× 237 1.3× 250 1.6× 428 3.4× 30 1.7k
Adrian Gericke Germany 23 577 0.8× 262 0.5× 148 0.8× 309 2.0× 131 1.0× 113 2.0k
Miguel Rivera Spain 25 580 0.8× 798 1.5× 104 0.6× 174 1.1× 213 1.7× 90 1.7k
Cibele Rocha‐Resende Brazil 18 714 1.0× 759 1.4× 242 1.3× 155 1.0× 151 1.2× 30 1.6k
Inés Stella Argentina 18 363 0.5× 263 0.5× 114 0.6× 245 1.6× 125 1.0× 31 1.2k
Tarja Kunnas Finland 22 303 0.4× 230 0.4× 126 0.7× 137 0.9× 132 1.0× 68 1.2k
James T. Colston United States 18 452 0.6× 376 0.7× 194 1.0× 184 1.2× 106 0.8× 30 1.0k
Eugene Lin United States 17 486 0.7× 247 0.5× 256 1.4× 251 1.6× 92 0.7× 22 1.3k
Elisa Villalobos Chile 13 454 0.6× 492 0.9× 162 0.9× 180 1.1× 123 1.0× 20 1.1k

Countries citing papers authored by Madhu V. Singh

Since Specialization
Citations

This map shows the geographic impact of Madhu V. Singh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Madhu V. Singh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Madhu V. Singh more than expected).

Fields of papers citing papers by Madhu V. Singh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Madhu V. Singh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Madhu V. Singh. The network helps show where Madhu V. Singh may publish in the future.

Co-authorship network of co-authors of Madhu V. Singh

This figure shows the co-authorship network connecting the top 25 collaborators of Madhu V. Singh. A scholar is included among the top collaborators of Madhu V. Singh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Madhu V. Singh. Madhu V. Singh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Singh, Madhu V., et al.. (2024). Novel components in the nuclear factor-kappa B (NF-κB) signaling pathways of endothelial cells under hyperglycemic-ischemic conditions. Frontiers in Cardiovascular Medicine. 11. 1345421–1345421. 3 indexed citations
2.
Mani, Arul M., et al.. (2024). miRNA‐6236 Regulation of Postischemic Skeletal Muscle Angiogenesis. Journal of the American Heart Association. 13(23). e035923–e035923.
3.
Singh, Madhu V. & Ayotunde O. Dokun. (2023). Diabetes mellitus in peripheral artery disease: Beyond a risk factor. Frontiers in Cardiovascular Medicine. 10. 1148040–1148040. 17 indexed citations
4.
Mani, Arul M., et al.. (2023). Endothelial Progenitor Cells and Macrophage Subsets Recruitment in Postischemic Mouse Hind Limbs. Journal of Vascular Research. 60(3). 148–159. 2 indexed citations
5.
Wang, Runping, Yongjun Lu, Michael Z. Cicha, et al.. (2019). TMEM16B determines cholecystokinin sensitivity of intestinal vagal afferents of nodose neurons. JCI Insight. 4(5). 9 indexed citations
6.
Abboud, François M. & Madhu V. Singh. (2017). Autonomic regulation of the immune system in cardiovascular diseases. AJP Advances in Physiology Education. 41(4). 578–593. 25 indexed citations
7.
Singh, Madhu V., Paari Dominic Swaminathan, Elizabeth D. Luczak, et al.. (2012). MyD88 mediated inflammatory signaling leads to CaMKII oxidation, cardiac hypertrophy and death after myocardial infarction. Journal of Molecular and Cellular Cardiology. 52(5). 1135–1144. 114 indexed citations
8.
Purohit, Anil, Paari Dominic Swaminathan, Biyi Chen, et al.. (2011). Abstract 14037: Angiotensin II Promotes Atrial Fibrillation in Mice by CaMKII Oxidation. Circulation. 124. 1 indexed citations
9.
He, B. Julie, Mei-ling A. Joiner, Madhu V. Singh, et al.. (2011). Oxidation of CaMKII determines the cardiotoxic effects of aldosterone. Nature Medicine. 17(12). 1610–1618. 195 indexed citations
10.
Gao, Zhan, Madhu V. Singh, Duane D. Hall, et al.. (2011). Catecholamine-Independent Heart Rate Increases Require Ca 2+ /Calmodulin-Dependent Protein Kinase II. Circulation Arrhythmia and Electrophysiology. 4(3). 379–387. 25 indexed citations
11.
Singh, Madhu V. & Mark E. Anderson. (2011). Is CaMKII a link between inflammation and hypertrophy in heart?. Journal of Molecular Medicine. 89(6). 537–543. 40 indexed citations
12.
Wu, Yuejin, Zhan Gao, Biyi Chen, et al.. (2009). Calmodulin kinase II is required for fight or flight sinoatrial node physiology. Proceedings of the National Academy of Sciences. 106(14). 5972–5977. 118 indexed citations
13.
Singh, Madhu V., Ann M. Kapoun, Linda S. Higgins, et al.. (2009). Ca2+/calmodulin-dependent kinase II triggers cell membrane injury by inducing complement factor B gene expression in the mouse heart. Journal of Clinical Investigation. 119(4). 986–96. 92 indexed citations
14.
Singh, Madhu V., et al.. (2004). Molecular and Genetic Characterization of a Taf1p Domain Essential for Yeast TFIID Assembly. Molecular and Cellular Biology. 24(11). 4929–4942. 14 indexed citations
15.
Singh, Madhu V. & P. Anthony Weil. (2002). A method for plasmid purification directly from yeast. Analytical Biochemistry. 307(1). 13–17. 49 indexed citations
16.
Singh, Madhu V. & Kowichi Jimbow. (1998). Tyrosinase transfection produces melanin synthesis and growth retardation in glioma cells. Melanoma Research. 8(6). 493–498. 9 indexed citations
17.
Singh, Madhu V., et al.. (1997). Influence of vanadium on acclimatization of humans to high altitude. International Journal of Biometeorology. 40(2). 95–98. 6 indexed citations
18.
Reddy, Doodipala Samba, Madhu V. Singh, & Kanwaljit Chopra. (1996). Signalling mechanisms of cardiac hypertrophy. Indian Journal of Pharmacology. 28(2). 58. 2 indexed citations
19.
Malhotra, S. K., et al.. (1995). Rat glioma cell line as a model for astrogliosis.. PubMed. 82(328). 39–51. 8 indexed citations
20.
Singh, Madhu V., et al.. (1986). Antiarrhythmic effect of calcium slow channel blockers (verapamil, nifedipine and diltiazem) in ventricular arrhythmias induced by coronary artery occlusion in dogs.. PubMed. 24(5). 287–91. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026